Please be advised that AstraZeneca has transferred all rights for LUMOXITI® (moxetumomab pasudotox-tdfk) to Innate Pharma S.A. as of April 1, 2020. For questions or assistance, please call InnateCares, Monday through Friday, 8 am – 8 pm Eastern Time at 1-844-694-6628.
Fill this form out to receive assistance from Access 360 for your FASENRA prescription.
.png "FASENRA Savings Program Affordability Information")
This resource explains affordability options for FASENRA if you are eligible.
